Packaging Coordinators, Inc. (PCI) will acquire Penn Pharmaceutical Services Limited (Penn Pharma), which is headquartered in the United Kingdom and operates regional offices in Pennsylvania and Japan. Penn Pharma’s drug development, manufacturing, and packaging services complement PCI’s clinical-trial and commercial-supply services. Recently, Penn Pharma opened a new manufacturing facility for the development and manufacturing of solid oral-dose products containing highly potent compounds. In 2014, Penn launched a capacity expansion project for large-scale commercial manufacturing and packaging. PCI also expanded both its global operations in North America and Europe and announced cold-chain infrastructure expansions for storage, logistics, and support for refrigerated packaging operations. PCI will also open a North American storage and distribution facility for investigational products in September, 2014.
“With Penn Pharma’s services, we can partner with clients at the very earliest stages of drug development to support them with drug formulation, analytical development, drug manufacturing, clinical packaging, global distribution, and ultimately supporting the product’s commercial launch. This addition expands our vision of lifecycle support from clinical trials through commercialization,” said Bill Mitchell, president and CEO of PCI, in a press release.